{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:41Z","timestamp":1789726241529,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening severe cutaneous adverse reaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to study fatal DRESS cases using FAERS database and systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of the FDA Adverse Event Reporting System (FAERS) database were extracted and manipulated. Articles from Pubmed, Embase and CINAHL databases were screened.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>0.13% of the adverse events submitted to FAERS was identified as DRESS and the percentage of fatal cases was up to 6.62%. The top five drugs calculated to induce DRESS with the highest number of reported cases were allopurinol, lamotrigine, vancomycin, amoxicillin and carbamazepine. The top five drugs statistically related to fatal outcome with the highest number of reported cases were allopurinol, vancomycin, trimethoprim, sulfamethoxazole and lamotrigine. Skin manifestations remained the main reason for admission and the average time from dose to rash onset was 27.19 days. The most commonly cited culprit medication type were antibiotics (50.00%), anti-gout agents (15.38%) and anti-epileptic drug (11.54%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We discussed fatal cases of DRESS through FAERS system and case reports, hoping to raise awareness when using relevant drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1490334","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T01:19:59Z","timestamp":1734311999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases"],"prefix":"10.3389","volume":"15","author":[{"given":"Chunsu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjiao","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome \/ drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.96351","article-title":"Allopurinol-induced DRESS syndrome","volume":"44","author":"Yaylac\u0131","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.1.71","article-title":"Allopurinol-induced DRESS syndrome mimicking biliary obstruction","volume":"20","author":"Choi","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"AB273","DOI":"10.1016\/j.jaci.2013.12.968","article-title":"Are proton pump inhibitors(PPI) naive? A case of drug reaction with eosinophilia and systemic symptom (DRESS) secondary to lansoprazole","volume":"133","author":"Uppalapati","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8985-21","article-title":"Atypical, levetiracetam-induced hypersensitivity syndrome complicated by fulminant liver failure in a patient undergoing hemodialysis","volume":"61","author":"Sato","year":"2022","journal-title":"Internal Med (Tokyo Japan)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc2201245","article-title":"Case 32-2022: A 76-year-old man with postoperative cardiogenic shock and diffuse rash","volume":"387","author":"Desai","year":"2022","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.312","article-title":"A case of severe erosive enterocolitis secondary to cytomegalovirus reactivation in a patient with DRESS syndrome: 1474","volume":"112","author":"Boumitri","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418764973","article-title":"Dolutegravir as a trigger for DRESS syndrome","volume":"29","author":"Martin","year":"2018","journal-title":"Int J STD AIDS"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/17843286.2017.1401314","article-title":"DRESS syndrome following exposure to Nabum\u00e9tone","volume":"72","author":"Sibille","year":"2017","journal-title":"Acta Clinica Belgica: Int J Clin Lab Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.rmr.2017.02.007","article-title":"DRESS syndrome secondary to pyrazinamide: An uncommon complication of tuberculosis treatment","volume":"35","author":"Kombila","year":"2018","journal-title":"Rev Des maladies respiratoires"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.84991","article-title":"DRESSing up to phenytoin","volume":"43","author":"Gude","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/all.13252","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome and tuberculosis: Case report","volume":"72","author":"Montecchiani","year":"2017","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e22509","DOI":"10.1097\/md.0000000000022509","article-title":"Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report","volume":"99","author":"He","year":"2020","journal-title":"Medicine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3384-7","article-title":"A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation","volume":"27","author":"Drago","year":"2016","journal-title":"Osteoporosis international: J established as result cooperation between Eur Foundation Osteoporosis Natl Osteoporosis Foundation USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13194","article-title":"A fatal case of drug-induced hypersensitivity syndrome complicated by multiple autoimmune disorders including bullous pemphigoid","volume":"34","author":"Plost","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1142","article-title":"Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"32","author":"Miller Quidley","year":"2012","journal-title":"Pharmacotherapy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.06.010","article-title":"Giant cell myocarditis in hypersensitivity reactions: is an early diagnose possible","volume":"115","author":"Micozzi","year":"2015","journal-title":"Ann allergy Asthma immunology: Off Publ Am Coll Allergy Asthma Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-3-200902030-00027","article-title":"Hypersensitivity myocarditis associated with azithromycin exposure","volume":"150","author":"Pursnani","year":"2009","journal-title":"Ann Internal Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"AB111","DOI":"10.1016\/j.jaad.2010.09.740","article-title":"Is minocycline a safe treatment for acne","volume":"64","author":"San Nicasio","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2017.12.009","article-title":"Late recurrence of fulminant myocarditis related to HSS\/DRESS","volume":"60","author":"Ard\u00e9rius","year":"2018","journal-title":"Cor et Vasa"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2012.714441","article-title":"Purtscher-like retinopathy related to drug-induced hypersensitivity syndrome","volume":"20","author":"Coban-Karatas","year":"2012","journal-title":"Ocular Immunol Inflammation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000898","article-title":"Probable drug eruption eosinophilia and systemic symptoms due to colistimethate sodium: A challenging case report","volume":"28","author":"Karimpour","year":"2020","journal-title":"Infect Dis Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2012.07.016","article-title":"Vancomycin-induced DRESS with evidence of T-cell activation in a 22-month-old patient","volume":"109","author":"Kitcharoensakkul","year":"2012","journal-title":"Ann allergy Asthma immunology: Off Publ Am Coll Allergy Asthma Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2420","article-title":"Severe agranulocytosis in two patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"96","author":"Kato","year":"2016","journal-title":"Acta dermato-venereologica"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16415","article-title":"Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"49","author":"Takamiyagi","year":"2022","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0087-OA","article-title":"Morphologic spectrum of lymphadenopathy in drug reaction with eosinophilia and systemic symptoms syndrome","volume":"146","author":"Chen","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.34.1.91","article-title":"Leflunomide induced atypical DRESS: A case report and literature review","volume":"34","author":"Fatima","year":"2023","journal-title":"Mediterr J Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamadermatol.2023.4450","article-title":"Management of adult patients with drug reaction with eosinophilia and systemic symptoms: A delphi-based international consensus","volume":"160","author":"Br\u00fcggen","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13667","article-title":"Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients","volume":"47","author":"Liu","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2021-0156","article-title":"Allopurinol-induced severe cutaneous adverse reactions in Vietnamese: the role of HLA alleles and other risk factors","volume":"23","author":"Ha Pham","year":"2022","journal-title":"Pharmacogenomics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0733-7","article-title":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report","volume":"26","author":"Kim","year":"2020","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mayocp.2016.03.006","article-title":"Management of psychotropic drug-induced DRESS syndrome: A systematic review","volume":"91","author":"Bommersbach","year":"2016","journal-title":"Mayo Clinic Proc"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions","volume":"93","author":"Mullan","year":"2019","journal-title":"HLA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1190","article-title":"and CYP2C9*3 as predictors of phenytoin hypersensitivity in east asians","volume":"105","author":"Su","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.06.024","article-title":"Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis","volume":"60","author":"Deng","year":"2018","journal-title":"Seizure"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.03.030","article-title":"Immune-mediated reactions to vancomycin: A systematic case review and analysis","volume":"116","author":"Minhas","year":"2016","journal-title":"Ann allergy Asthma immunology: Off Publ Am Coll Allergy Asthma Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.899149","article-title":"and subsequent teicoplanin administration: A case report","volume":"17","author":"Miyazu","year":"2016","journal-title":"Am J Case Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.056","article-title":"Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A\u221732:01-positive vancomycin-induced DRESS sharing an HLA class II haplotype","volume":"147","author":"Nakkam","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.04.006","article-title":"A rapid allele-specific assay for HLA-A*32:01 to identify patients at risk for vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"21","author":"Rwandamuriye","year":"2019","journal-title":"J Mol Diagnostics: JMD"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030704","article-title":"Heart in DRESS\": cardiac manifestations, treatment and outcome of patients with drug reaction with eosinophilia and systemic symptoms syndrome: A systematic review","volume":"11","author":"Radovanovic","year":"2022","journal-title":"J Clin Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Trans Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13601-015-0073-8","article-title":"Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back","volume":"5","author":"Schrijvers","year":"2015","journal-title":"Clin Trans Allergy"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.10.032","article-title":"Therapeutic management of DRESS: a retrospective study of 38 cases","volume":"72","author":"Funck-Brentano","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15294","article-title":"Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"47","author":"Tohyama","year":"2020","journal-title":"J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome \/ drug reaction with eosinophilia and systemic symptoms. Part II. Diagnosis and management","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","article-title":"Identification of thymus and activation-regulated chemokine (TARC\/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)\/drug rash with eosinophilia and systemic symptoms (DRESS)","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.08.010","article-title":"Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS\/TEN in epilepsy patients","volume":"63","author":"Kumkamthornkul","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2477","article-title":"Differential expression profile of Th1\/Th2-associated chemokines characterizes Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN) and drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS) as distinct entities","volume":"25","author":"Miyagawa","year":"2015","journal-title":"Eur J Dermatology: EJD"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14890","article-title":"The measurement of drug-induced interferon \u03b3-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions","volume":"32","author":"Suthumchai","year":"2018","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14701","article-title":"In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions","volume":"175","author":"Klaewsongkram","year":"2016","journal-title":"Br J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12109","article-title":"In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions","volume":"168","author":"Polak","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1490334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T01:20:02Z","timestamp":1734312002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1490334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2024.1490334"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1490334","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"article-number":"1490334"}}